JP2011504108A5 - - Google Patents

Download PDF

Info

Publication number
JP2011504108A5
JP2011504108A5 JP2010534507A JP2010534507A JP2011504108A5 JP 2011504108 A5 JP2011504108 A5 JP 2011504108A5 JP 2010534507 A JP2010534507 A JP 2010534507A JP 2010534507 A JP2010534507 A JP 2010534507A JP 2011504108 A5 JP2011504108 A5 JP 2011504108A5
Authority
JP
Japan
Prior art keywords
peptide
phe
fusion protein
cancer
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010534507A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011504108A (ja
JP5385910B2 (ja
Filing date
Publication date
Priority claimed from ES200703052A external-priority patent/ES2328776B1/es
Application filed filed Critical
Publication of JP2011504108A publication Critical patent/JP2011504108A/ja
Publication of JP2011504108A5 publication Critical patent/JP2011504108A5/ja
Application granted granted Critical
Publication of JP5385910B2 publication Critical patent/JP5385910B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010534507A 2007-11-19 2008-11-14 スクルフィンに結合する能力を有するペプチドおよびその用途 Expired - Fee Related JP5385910B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200703052 2007-11-19
ES200703052A ES2328776B1 (es) 2007-11-19 2007-11-19 Peptidos con capacidad para unirse a escurfina y aplicaciones.
PCT/ES2008/000716 WO2009065982A1 (es) 2007-11-19 2008-11-14 Péptidos con capacidad para unirse a escurfina y aplicaciones

Publications (3)

Publication Number Publication Date
JP2011504108A JP2011504108A (ja) 2011-02-03
JP2011504108A5 true JP2011504108A5 (enExample) 2012-01-12
JP5385910B2 JP5385910B2 (ja) 2014-01-08

Family

ID=40409793

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010534507A Expired - Fee Related JP5385910B2 (ja) 2007-11-19 2008-11-14 スクルフィンに結合する能力を有するペプチドおよびその用途

Country Status (11)

Country Link
US (1) US8524860B2 (enExample)
EP (1) EP2223998B1 (enExample)
JP (1) JP5385910B2 (enExample)
CN (1) CN101903514B (enExample)
AU (1) AU2008327792B2 (enExample)
BR (1) BRPI0819311A2 (enExample)
CA (1) CA2706201A1 (enExample)
ES (1) ES2328776B1 (enExample)
MX (1) MX2010005520A (enExample)
RU (1) RU2502741C2 (enExample)
WO (1) WO2009065982A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8080518B2 (en) * 2007-12-05 2011-12-20 Arbor Vita Corporation Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
PT2440231T (pt) 2009-06-10 2020-01-08 Nono Inc Co-administração de um agente ligado a um peptido de internalização tat com um inibidor de desgranulação de mastócitos
JP6665102B2 (ja) * 2014-02-21 2020-03-13 セレクティスCellectis 制御性t細胞をインサイチューで阻害するための方法
ES2665543B1 (es) * 2016-10-26 2019-02-12 Fundacion Para La Investig Medica Aplicada Péptidos de unión a FOXP3 y usos de los mismos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698015A (en) * 1995-05-19 1997-12-16 Nikko Company Conductor paste for plugging through-holes in ceramic circuit boards and a ceramic circuit board having this conductor paste
CA2314267A1 (en) * 1997-12-10 1999-06-17 Washington University Anti-pathogen system and methods of use thereof
CA2339409A1 (en) * 1998-08-11 2000-02-24 Darwin Discovery Ltd. Identification of the gene causing the mouse scurfy phenotype and its human ortholog
AU2001238144A1 (en) * 2000-02-09 2001-08-20 Agensys, Inc. 83p5g4: a tissue specific protein highly expressed in prostate cancer
US20030191073A1 (en) * 2001-11-07 2003-10-09 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
US7507542B2 (en) * 2001-05-08 2009-03-24 Ucb Sa Method for regulating immune function using the FOXP3 protein
WO2006044864A2 (en) * 2004-10-19 2006-04-27 Duke University Vaccine adjuvant
US20100061984A1 (en) * 2006-01-20 2010-03-11 The Trustees Of The University Of Pennsylvania Compositions and methods for modulation of suppressor t cell activation

Similar Documents

Publication Publication Date Title
CA2336597C (en) Hepatitis c inhibitor peptides
JP2008538183A5 (enExample)
JP2017538682A5 (enExample)
JP2010540453A5 (enExample)
JP2019512478A5 (enExample)
JP2008525033A5 (enExample)
JP2017160222A5 (enExample)
FI3393510T3 (fi) Zika-virusrokote
JP2012000112A5 (enExample)
JP2006025793A5 (enExample)
JP2008505985A5 (enExample)
JP2021524270A5 (enExample)
JP2021524275A5 (enExample)
JP2013537418A5 (enExample)
JP2021535761A5 (enExample)
JP2021516991A5 (enExample)
JP2001518304A5 (enExample)
SA99200617A (ar) " مركبات ثلاثية الببتيد مثبطة لإلتهاب الكبد c "
JP2023529839A5 (enExample)
JP2019505567A5 (enExample)
JP2014525939A5 (enExample)
JP2014510699A5 (enExample)
JP2011139704A5 (enExample)
JP2006158399A5 (ja) 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤
RU2010125199A (ru) Пептиды со способностью связываться со скурфином и их применение